METHOD OF CONTROLLING CARBAMOYL IMPURITY IN PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN

摘要

The present invention relates to a method of controlling the level of a carbamoyl analogue of dabigatran etexilate in pharmaceutical compositions comprising dabigatran etexilate or a pharmaceutically acceptable salt thereof, wherein said method comprises packing the pharmaceutical composition in a packaging system comprising a desiccant.